Wei, Lin and Weissfeld's marginal analysis of multivariate failure time data: Should it be applied to a recurrent events outcome?

Statistical Methods in Medical Research

Volumn 16, Issue 2, 2007, Pages 103-122

  Metcalfe, Chris ^a   Thompson, Simon G ^b  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b MRC BIOSTATISTICS UNIT   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; THIOTEPA;

ARTICLE; BLADDER CANCER; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CORRELATION ANALYSIS; HOSPITAL ADMISSION; HUMAN; ISCHEMIC HEART DISEASE; MATHEMATICAL COMPUTING; MONTE CARLO METHOD; MULTIVARIATE ANALYSIS; OUTCOMES RESEARCH; POISSON DISTRIBUTION; PROPORTIONAL HAZARDS MODEL; RECURRENCE RISK; RECURRENT CANCER; REGRESSION ANALYSIS; SIMULATION; TIME; TREATMENT FAILURE; TREATMENT OUTCOME; UNITED KINGDOM;

BIOMETRY; DATA INTERPRETATION, STATISTICAL; GREAT BRITAIN; MULTIVARIATE ANALYSIS; OUTCOME ASSESSMENT (HEALTH CARE); PROPORTIONAL HAZARDS MODELS;

EID: 34247521874     PISSN: 09622802     EISSN: None     Source Type: Journal    
DOI: 10.1177/0962280206071926     Document Type: Article

References (37)

1. Wei LJ, Lin DY, Weissfeld L. Regression-analysis of multivariate incomplete failure time data by modeling marginal distributions. Journal of the American Statistical Association 1989; 84: 1065-73.
2. Neaton JD, Wentworth DN, Rhame F, Hogan C, Abrams DI, Deyton L. Considerations in choice of a clinical end-point for AIDS clinical trials. Statistics in Medicine 1994; 13: 2107-25.
3. Walker AS, Babiker AG, Darbyshire JH. Analysis of multivariate failure-time data from HIV clinical trials. Controlled Clinical Trials 2000; 21: 75-93.
4. Therneau TM, Grambsch PM. Modeling survival data. Extending the Cox model. Springer, 2000.
5. Babiker AG, Darbyshire JH, Peto TEA, Walker AS. Issues in the design and analysis of therapeutic trials in human immunodeficiency virus infection. Journal of the Royal Statistical Society Series A - Statistics in Society 1998; 161: 239-49.
6. Byar DP, Blackard C. Comparisons of placebo, pyridoxine, and topical thiotepa in preventing recurrence of stage I bladder cancer. Urology 1977; 10: 556-61.
7. Byar DP. The Veterans Administration study of chemoprophylaxis for recurrent stage I bladder tumours: comparisons of placebo, pyridoxine and topical thiotepa. In Pavone-Macaluso M, Smith PH, Edsmyr F eds. Bladder tumours and other topics in urological oncology. Plenum, 1980.
8. Cox DR. Regression models and life-tables. Journal of the Royal Statistical Society, Series B (Methodological) 1972; 34: 187-220.
9. Cox DR. Partial likelihood. Biometrika 1975; 62: 269-76.
10. Prentice RL, Williams BJ, Peterson AV. On the regression-analysis of multivariate failure time data. Biometrika 1981; 68: 373-9.
11. Lin DY. Cox regression-analysis of multivariate failure time data - the marginal approach. Statistics in Medicine 1994; 13: 2233-47.
12. Wei LJ, Glidden DV. An overview of statistical methods for multiple failure time data in clinical trials. Statistics in Medicine 1997; 16: 833-9.
13. Mahé C, Chevret S. Estimation of the treatment effect in a clinical trial when recurrent events define the endpoint. Statistics in Medicine 1999; 18: 1821-9.
14. Ghosh D. Methods for analysis of multiple events in the presence of death. Controlled Clinical Trials 2000; 21: 115-26.
15. Barai U, Teoh N. Multiple statistics for multiple events, with application to repeated infections in the growth factor studies. Statistics in Medicine 1997; 16: 941-9.
16. Metcalfe C, Thompson SG, Cowie MR, Sharples LD. The use of hospital admission data as a measure of outcome in clinical studies of heart failure. European Heart Journal 2003; 24: 105-12.
17. Oakes D. Reloinders. In Klein JP, God PK eds. Survival analysis: state of the art. Kluwer Academic Publishers, 1992.
18. Cook RJ, Lawless JF. Discussion of paper by Wei and Glidden. Statistics in Medicine 1997; 16: 841-3.
19. Tuli S, Drake J, Lawless J, Wigg M, Lamberti-Pasculli M. Risk factors for repeated cerebrospinal shunt failures in pediatric patients with hydrocephalus. Journal of Neurosurgery 2000; 92: 31-8.
20. Lipschutz KH, Snapinn SM. Discussion of paper by Wei and Glidden. Statistics in Medicine 1997; 16: 841-51.
21. Kelly PJ, Lim LL-Y. Survival analysis for recurrent event data: an application to childhood infectious diseases. Statistics in Medicine 2000; 19: 13-33.
22. Metcalfe C, Thompson SG. The importance of varying the event generation process in simulation studies of statistical methods of recurrent events. Statistics in Medicine 2006; 25: 165-179.
23. StataCorp. Stata statistical software: release 8.0. Stata Corporation, 2003.
24. Morgan BJT. Elements of simulation. Chapman and Hall, 1984.
25. Rogers WH. sg17: regression standard errors in clustered samples. Stata Technical Bulletin 1993; 13: 19-23.
26. Schoenfeld D. Chi-squared goodness-of-fit tests for the proportional hazards regression model. Biometrika 1980; 67: 145-53.
27. Grambsch PM, Therneau TM. Proportional hazards tests and diagnostics based on weighted residuals. Biometrika 1994; 81: 515-26.
28. Schoenfeld D. Partial residuals for the proportional hazards regression model. Biometrika 1982; 69: 239-41.
29. Stata Corp. Survival analysis and epidemiological tables. StataCorp, 2003.
30. Gail MH, Wieand S, Piantadosi S. Biased estimates of treatment effect in randomized experiments with nonlinear regressions and omitted covariates. Biometrika 1984; 71: 431-44.
31. Bretagnolle J, Huber-Carol C. Effects of omitting covariates in Cox's model for survival data. Scandinavian Journal of Statistics 1988; 15: 125-38.
32. Henderson R, Oman P. Effect of frailty on marginal regression estimates in survival analysis. Journal of the Royal Statistical Society Series B-Methodology 1999; 61: 367-79.
33. Aalen OO. Effects of frailty in survival analysis. Statistical Methods in Medical Research 1994; 3: 227-43.
34. Blane D, Hart CL, Davey Smith G, Gillis CR, Hole DJ, Hawthorne VM. Association of cardiovascular disease risk factors with socto-economic position during childhood and during adulthood. BMJ 1996; 313: 1434-8.
35. Davey Smith G, Hart C, Blanc D, Gillis C, Hawthorne V. Lifetime socio-economic position and mortality: prospective observational study. BMJ 1997; 314: 547-52.
36. Yang Y, Ying Z. Marginal proportional hazards models for multiple event-time data. Biometrika 2001; 88: 581-6.
37. Hougaard P. Analysis of multivariate survival data. Springer-Verlag, 2000.